UBS Group’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1
| Closed | -$1 | – | 9014 |
|
|
2023
Q4 | $1 | Sell |
1
-101
| -99% | -$101 | ﹤0.01% | 8002 |
|
|
2023
Q3 | $114 | Buy |
102
+101
| +10,100% | +$113 | ﹤0.01% | 7706 |
|
|
2023
Q2 | $1 | Sell |
1
-3,739
| -100% | -$3.74K | ﹤0.01% | 7729 |
|
|
2023
Q1 | $3.96K | Sell |
3,740
-527
| -12% | -$559 | ﹤0.01% | 7151 |
|
|
2022
Q4 | $10K | Sell |
4,267
-1,273
| -23% | -$2.99K | ﹤0.01% | 7390 |
|
|
2022
Q3 | $24K | Buy |
5,540
+5,539
| +553,900% | +$24K | ﹤0.01% | 6093 |
|
|
2022
Q2 | $0 | Sell |
1
-1,006
| -100% | – | ﹤0.01% | 10516 |
|
|
2022
Q1 | $9K | Buy |
1,007
+501
| +99% | +$4.48K | ﹤0.01% | 7579 |
|
|
2021
Q4 | $6K | Buy |
506
+505
| +50,500% | +$5.99K | ﹤0.01% | 8237 |
|
|
2021
Q3 | $0 | Sell |
1
-151
| -99% | – | ﹤0.01% | 9481 |
|
|
2021
Q2 | $3K | Buy |
152
+86
| +130% | +$1.7K | ﹤0.01% | 7800 |
|
|
2021
Q1 | $2K | Buy |
+66
| New | +$2K | ﹤0.01% | 7687 |
|
|
2020
Q4 | – | Sell |
-252
| Closed | -$9K | – | 8027 |
|
|
2020
Q3 | $9K | Buy |
252
+87
| +53% | +$3.11K | ﹤0.01% | 6112 |
|
|
2020
Q2 | $7K | Buy |
165
+67
| +68% | +$2.84K | ﹤0.01% | 6406 |
|
|
2020
Q1 | $4K | Buy |
98
+38
| +63% | +$1.55K | ﹤0.01% | 6531 |
|
|
2019
Q4 | $10K | Buy |
60
+42
| +233% | +$7K | ﹤0.01% | 6244 |
|
|
2019
Q3 | $7K | Buy |
+18
| New | +$7K | ﹤0.01% | 6411 |
|
|
2019
Q2 | – | Sell |
-6
| Closed | -$7K | – | 7427 |
|
|
2019
Q1 | $7K | Buy |
+6
| New | +$7K | ﹤0.01% | 6220 |
|
|
2018
Q4 | – | Sell |
-12
| Closed | -$18K | – | 7543 |
|
|
2018
Q3 | $18K | Buy |
12
+10
| +500% | +$15K | ﹤0.01% | 5963 |
|
|
2018
Q2 | $3K | Sell |
2
-2
| -50% | -$3K | ﹤0.01% | 6758 |
|
|
2018
Q1 | $45K | Hold |
4
| – | – | ﹤0.01% | 4947 |
|
|
2017
Q4 | $58K | Buy |
4
+1
| +33% | +$14.5K | ﹤0.01% | 4786 |
|
|
2017
Q3 | $84K | Buy |
3
+1
| +50% | +$28K | ﹤0.01% | 4552 |
|
|
2017
Q2 | $93K | Hold |
2
| – | – | ﹤0.01% | 4332 |
|
|
2017
Q1 | $128K | Hold |
2
| – | – | ﹤0.01% | 4082 |
|
|
2016
Q4 | $159K | Hold |
2
| – | – | ﹤0.01% | 4091 |
|
|
2016
Q3 | $303K | Sell |
2
-1
| -33% | -$152K | ﹤0.01% | 3460 |
|
|
2016
Q2 | $323K | Buy |
3
+1
| +50% | +$108K | ﹤0.01% | 3448 |
|
|
2016
Q1 | $294K | Hold |
2
| – | – | ﹤0.01% | 3509 |
|
|
2015
Q4 | $281K | Hold |
2
| – | – | ﹤0.01% | 3548 |
|
|
2015
Q3 | $334K | Buy |
2
+1
| +100% | +$167K | ﹤0.01% | 3363 |
|
|
2015
Q2 | $301K | Buy |
+1
| New | +$301K | ﹤0.01% | 3588 |
|